Tirzepatide Risks and Side Effects: What to Expect and When to Act

Which side effects do most people on tirzepatide actually notice?

The pattern is consistent and well-documented. In the SURMOUNT-1 trial, the most frequently reported effects were nausea, diarrhoea, vomiting, constipation, and indigestion, findings that the NHS medicines page for tirzepatide reflects in its own summary. Fatigue, headache, dizziness, and belching also appear, particularly in the early weeks. Injection-site reactions (mild redness or itching at the spot where the pen was used) are possible but uncommon.

The timing matters. Side effects tend to be most noticeable in the first week or two after starting and again briefly after each dose increase. They're not random; they're the body adjusting to a slower gastric-emptying rate and changed appetite signals. For most people they ease considerably once the body acclimates, which is precisely why treatment opens at 2.5mg before a prescriber moves the dose up.

Practical things that genuinely help: eating smaller portions, avoiding very fatty or rich food, staying well hydrated, and not lying down immediately after eating. Our tirzepatide side effects guide covers coping strategies in more detail, drawn from prescriber experience and NHS advice.

One detail patients often miss: tirzepatide is kept refrigerated. If your pen has been sitting on the kitchen counter rather than in the fridge door for more than the period stated in the Patient Information Leaflet, check the leaflet before using it. Temperature matters for the medicine's stability.

What are the more serious risks, and how likely are they?

Serious adverse events are uncommon, but knowing the signs is non-negotiable. The most clinically significant risk is acute pancreatitis. On 29 January 2026, the MHRA issued a Drug Safety Update for GLP-1 receptor agonists (including tirzepatide) flagging acute pancreatitis as an infrequent but potentially serious side effect. If you develop severe, persistent stomach pain that spreads towards your back, with or without vomiting, stop the injection and get urgent medical help. Do not wait to see if it passes.

Gallbladder problems are also recognised. Rapid weight loss of any cause can increase the risk of gallstones, and symptoms such as upper-right abdominal pain, nausea after fatty meals, or yellowing of the skin or eyes should be assessed promptly by a doctor.

Dehydration is a secondary risk: prolonged vomiting or diarrhoea can reduce kidney function. If you are unable to keep fluids down for more than a day, seek advice. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 should not use tirzepatide; these are absolute contraindications listed in the medicine's prescribing information. If you want to understand the full picture before starting, our page on the risks of tirzepatide covers everything from rare serious events to the factors a prescriber weighs when assessing suitability.

Mood changes are reported by a small number of users. If you notice low mood, thoughts of self-harm, or significant changes in how you feel mentally, tell your prescriber or GP promptly. This applies to all GLP-1 medicines, and the MHRA monitors it through post-marketing surveillance.

When should you get medical help, and what counts as urgent?

There is a clear distinction between effects that are uncomfortable and those that need medical assessment. Get urgent help (call 999 or go to A&E) for: severe persistent abdominal pain radiating to the back; signs of a serious allergic reaction such as swelling of the face, throat, or tongue, difficulty breathing, or sudden widespread rash; rapid heartbeat with dizziness suggesting dehydration or cardiac involvement.

Contact your GP, prescriber, or NHS 111 for: symptoms that have not improved after two weeks on the same dose; inability to keep down fluids for more than 24 hours; yellowing of skin or eyes; significant changes in mood or mental health; any symptom you are unsure about. Our side effects resource page lists red-flag symptoms alongside the everyday ones so you can tell them apart at a glance.

If you suspect the medicine itself is counterfeit or from an unverified source, report this through the Yellow Card scheme alongside any adverse reaction. Counterfeit pens (some found to contain insulin rather than tirzepatide) have caused hospitalisations; this is one reason buying only through a pharmacy you can verify on the GPhC register matters so much.

Yellow Card reporting is open to patients and carers, not only clinicians. You can submit a report at yellowcard.mhra.gov.uk for any suspected side effect, however minor, and your report contributes to ongoing safety monitoring of the medicine in real-world use.

Who should not use tirzepatide, and what does a prescriber check?

Tirzepatide is not licensed for anyone under 18. It is not recommended during pregnancy, whilst breastfeeding, or for people actively trying to conceive; the MHRA advises using contraception during treatment and for a washout period after stopping before trying for a pregnancy. Women using oral contraceptives should also add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide slows gastric emptying enough to reduce oral contraceptive absorption.

Beyond the absolute contraindications, a prescriber will weigh your full medical history (existing GI conditions, kidney or liver disease, previous pancreatitis, current medications) before issuing a prescription. This is exactly the assessment that separates a legitimate clinical route from an unverified online seller. Every consultation at nume is personally reviewed by a GPhC-registered Independent Prescriber; you can read about our clinical team on our prescribers page. If you'd like a thorough breakdown of what to expect once you begin, our Mounjaro side effects page covers the full profile with additional context on monitoring, and you can also explore our dedicated pages on Mounjaro risks and side effects and the tirzepatide long-term risks that a prescriber will discuss with you before treatment starts. Ready to discuss your own situation? Start your free consultation and our prescribers will go through suitability and any side-effect concerns with you directly.